Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar V Parikh

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation TreatmentsRoumen V Milev, Peter Giacobbe, Sidney H Kennedy, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 11, 2026
A Chatbot for the Management of Bipolar Disorder: Using Retrieval-Augmented Generation With an Open-Weight Large Language Model to Answer Clinical Questions Based on the CANMAT and ISBD 2018 Guidelines for Bipolar Disorder: Un dialogueur pour la prise en charge du trouble bipolaire : utiliser la génération augmentée par récupération avec un grand modèle de langage (GML) à poids ouverts pour répondre aux questions cliniques fondées sur les lignes directrices de 2018 de CANMAT et de l'ISBD relatives au trouble bipolaireYash Mali, Zejiao Zeng, Kayoung Heo, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine|May 16, 2022
Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysisMehri Sajjadian, Raymond W Lam, Roumen Milev, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation TreatmentsRoumen V Milev, Peter Giacobbe, Sidney H Kennedy, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 11, 2026
A Chatbot for the Management of Bipolar Disorder: Using Retrieval-Augmented Generation With an Open-Weight Large Language Model to Answer Clinical Questions Based on the CANMAT and ISBD 2018 Guidelines for Bipolar Disorder: Un dialogueur pour la prise en charge du trouble bipolaire : utiliser la génération augmentée par récupération avec un grand modèle de langage (GML) à poids ouverts pour répondre aux questions cliniques fondées sur les lignes directrices de 2018 de CANMAT et de l'ISBD relatives au trouble bipolaireYash Mali, Zejiao Zeng, Kayoung Heo, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine|May 16, 2022
Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysisMehri Sajjadian, Raymond W Lam, Roumen Milev, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Pageof 19